María del Carmen Neipp López, P. López, J. Montes, J. S. Albero, Ángel Celada Rodríguez, A. Gálvez
{"title":"亚临床甲状腺功能减退对基层医疗保健区的影响","authors":"María del Carmen Neipp López, P. López, J. Montes, J. S. Albero, Ángel Celada Rodríguez, A. Gálvez","doi":"10.2174/1874216501105010008","DOIUrl":null,"url":null,"abstract":"Objective: Assess the prevalence of subclinical hypothyroidism in the general population of an urban health area and describe the main clinical and socio-demographic characteristics of patients with subclinical hypothyroidism. Method: A retrospective descriptive observational study. We reviewed case histories from June 2005 to July 2007. We analysed the following variables: General data: age and gender. Family background: thyroid pathology and other diseases. Personal background: cardiovascular, lung, autoimmunity, gynaeco-obsetric alterations, diabetes, hypertension (HT), dyslipidaemia, obesity, alterations of psychiatric haemotologic pathology, other laboratory data: TSH levels, free T4 levels, presence of antiperoxidase antibodies, total and partial cholesterol levels. Results: The prevalence of our sample of 100 patients enrolled in 8 months was 3.8% with a mean of 4.2% ± 1.3 SD in the general population aged over 14 years, of whom 79 were women and 21 were men. The; 13% were associated with type 2 diabetes mellitus, 23% with HT and 40% with dyslipidaemia. Being overweight or obese revealed a mean of 23%, TSH level in 6.92 � U/ml, range from 4,5 to 18,75� U/ml, while the mean free T4 was 1.16 ± 0.16 ng/ml. Conclusions: The prevalence of subclinical hypothyroidism was 3.8%. It was more frequent in women of a mean age of 46 years. Gynaecologic alternations were reported for 17% of females. The incidence of cardiovascular risk factors was relatively high: 13% with DM, 23% with HBP, 40% with dyslipidaemia and 23% with obesity. There are no common guidelines for subclinical hypothyroidism management. Therefore, the implementation and promotion of action guidelines are required in Primary Health Care.","PeriodicalId":88751,"journal":{"name":"The open endocrinology journal","volume":"5 1","pages":"8-13"},"PeriodicalIF":0.0000,"publicationDate":"2011-04-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Impact of Subclinic Hypothyroidism on a Basic Primary Healthcare Area\",\"authors\":\"María del Carmen Neipp López, P. López, J. Montes, J. S. Albero, Ángel Celada Rodríguez, A. Gálvez\",\"doi\":\"10.2174/1874216501105010008\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Objective: Assess the prevalence of subclinical hypothyroidism in the general population of an urban health area and describe the main clinical and socio-demographic characteristics of patients with subclinical hypothyroidism. Method: A retrospective descriptive observational study. We reviewed case histories from June 2005 to July 2007. We analysed the following variables: General data: age and gender. Family background: thyroid pathology and other diseases. Personal background: cardiovascular, lung, autoimmunity, gynaeco-obsetric alterations, diabetes, hypertension (HT), dyslipidaemia, obesity, alterations of psychiatric haemotologic pathology, other laboratory data: TSH levels, free T4 levels, presence of antiperoxidase antibodies, total and partial cholesterol levels. Results: The prevalence of our sample of 100 patients enrolled in 8 months was 3.8% with a mean of 4.2% ± 1.3 SD in the general population aged over 14 years, of whom 79 were women and 21 were men. The; 13% were associated with type 2 diabetes mellitus, 23% with HT and 40% with dyslipidaemia. Being overweight or obese revealed a mean of 23%, TSH level in 6.92 � U/ml, range from 4,5 to 18,75� U/ml, while the mean free T4 was 1.16 ± 0.16 ng/ml. Conclusions: The prevalence of subclinical hypothyroidism was 3.8%. It was more frequent in women of a mean age of 46 years. Gynaecologic alternations were reported for 17% of females. The incidence of cardiovascular risk factors was relatively high: 13% with DM, 23% with HBP, 40% with dyslipidaemia and 23% with obesity. There are no common guidelines for subclinical hypothyroidism management. Therefore, the implementation and promotion of action guidelines are required in Primary Health Care.\",\"PeriodicalId\":88751,\"journal\":{\"name\":\"The open endocrinology journal\",\"volume\":\"5 1\",\"pages\":\"8-13\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2011-04-22\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The open endocrinology journal\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.2174/1874216501105010008\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The open endocrinology journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/1874216501105010008","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Impact of Subclinic Hypothyroidism on a Basic Primary Healthcare Area
Objective: Assess the prevalence of subclinical hypothyroidism in the general population of an urban health area and describe the main clinical and socio-demographic characteristics of patients with subclinical hypothyroidism. Method: A retrospective descriptive observational study. We reviewed case histories from June 2005 to July 2007. We analysed the following variables: General data: age and gender. Family background: thyroid pathology and other diseases. Personal background: cardiovascular, lung, autoimmunity, gynaeco-obsetric alterations, diabetes, hypertension (HT), dyslipidaemia, obesity, alterations of psychiatric haemotologic pathology, other laboratory data: TSH levels, free T4 levels, presence of antiperoxidase antibodies, total and partial cholesterol levels. Results: The prevalence of our sample of 100 patients enrolled in 8 months was 3.8% with a mean of 4.2% ± 1.3 SD in the general population aged over 14 years, of whom 79 were women and 21 were men. The; 13% were associated with type 2 diabetes mellitus, 23% with HT and 40% with dyslipidaemia. Being overweight or obese revealed a mean of 23%, TSH level in 6.92 � U/ml, range from 4,5 to 18,75� U/ml, while the mean free T4 was 1.16 ± 0.16 ng/ml. Conclusions: The prevalence of subclinical hypothyroidism was 3.8%. It was more frequent in women of a mean age of 46 years. Gynaecologic alternations were reported for 17% of females. The incidence of cardiovascular risk factors was relatively high: 13% with DM, 23% with HBP, 40% with dyslipidaemia and 23% with obesity. There are no common guidelines for subclinical hypothyroidism management. Therefore, the implementation and promotion of action guidelines are required in Primary Health Care.